Literature DB >> 10528796

Comparative studies of modulatory effect to the function of rat peritoneal neutrophils treated with new quinolones.

Y Azuma1, P L Wang, M Shinohara, M Okamura, Y Inui, Y Suese, K Ohura.   

Abstract

Some of the immunological effects of a variety of new quinolones on adhesion, phagocytosis, and production of reactive oxygen intermediators in neutrophils were studied. Ofloxacin, lomefloxacin, fleroxacin, and levofloxacin potentiated the phagocytosis of Escherichia coli in neutrophils. Moreover, lomefloxacin, and sparfloxacin significantly potentiated adhesion of neutrophils. In contrast, tosufloxacin was effective in significantly and persistently potentiating the production of superoxide anion, whereas the other agents markedly inhibited such production. Furthermore, tosufloxacin was effective in significantly potentiating the production of hydrogen peroxide, whereas sparfloxacin markedly inhibited such production. These results suggest that the new quinolones at a therapeutic concentration may affect functions such as phagocytosis, and production of superoxide anion in neutrophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528796     DOI: 10.1016/s0165-2478(99)00112-1

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages.

Authors:  Yasutaka Azuma; Kiyoshi Ohura
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

2.  Alteration of constitutive apoptosis in neutrophils by quinolones.

Authors:  Yasutaka Azuma; Kiyoshi Ohura
Journal:  Inflammation       Date:  2003-06       Impact factor: 4.092

3.  Stress decreases contraction of the colon, and the effects of stress are different among the regions of the colon.

Authors:  Naoshige Ono; Sho Suzuki; Koichi Kawada; Taro Yamaguchi; Yasu-Taka Azuma
Journal:  J Vet Med Sci       Date:  2022-06-13       Impact factor: 1.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.